Chronic Kidney Disease Linked to Uncontrolled Blood Pressure
Second study shows ambulatory BP patterns not tied to cognitive impairment or frailty in CKD patients
Hypertension
HYPERTENSION
Statement Addresses Concerns About Heart Meds and COVID-19
Patients advised to continue ACE inhibitors/ARBs after researcher posits risk for severe COVID-19 infection.
CDC Updates Guidance on Evaluating, Testing for COVID-19 as More Tests Become Available
The Centers for Disease Control and Prevention has updated the guidance for evaluation of persons under investigation for coronavirus disease 2019 (COVID-19), expanding the criteria to a wider group of symptomatic patients.
RAS Blockade Discontinuation Tied With Death, MACE in Advanced Kidney Disease
Study findings suggest the benefits of continuing ACEi or ARB therapy outweigh the risks in CKD patients with an eGFR less than 30 mL/min/1.73 m2.
Intensive BP Control Has Positive Impact on Residual Life Span
Mean survival benefits varied from 6 months to 3 years for intensive versus standard BP control.
More Renal Side Effects Seen With Guideline-Recommended Chlorthalidone
No cardiovascular benefits found with chlorthalidone versus hydrochlorothiazide for hypertension treatment.
Amlodipine Better BP Drug for Lower Long-Term Risk for Gout
Compared with chlorthalidone and lisinopril, amlodipine associated with lower risk for gout.
Orthostatic Hypotension During Hypertension Treatment Not Tied to CVD Events
Medication doses do not need to be reduced in response to symptomless orthostatic hypotension, authors say.
Seasonal Sun Variation Tied to Hypertensive Disorders of Pregnancy
Risk for hypertensive disorder highest in women with estimated date of conception in June, August.
LV Hypertrophy May Explain Racial Disparities in Heart Failure
Some of the excess risk for heart failure explained by higher prevalence of malignant LVH in blacks.
Want to read more?
Please login or register first to view this content.
Next post in Cardiovascular Disease (CVD)
